Security key
79400X503
Decoy Therapeutics Inc. - Common Stock, $0.0001 par value per share (DCOY)
CUSIP: 79400X503
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 537
- Total 13F value
- $1,977
- Share change
- +537
- SEC-reported price per share
- $3.75
- Number of holders
- 5
- Value change
- +$1,977
- Number of buys
- 5
- Shares outstanding
- 7,157,222
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
5
Top holders
5
DCOY full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Decoy Therapeutics Inc. SEC filings
Decoy Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 79400X503
Recent filing periods:
Ownership snapshot
Top reported holders of DCOY - Decoy Therapeutics Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HRT FINANCIAL LP
Disclosed value leader
HRT FINANCIAL LP
Comparable rows
0/15
Latest evidence
30 Jun 2025
13F
3/4/5
Highest disclosed value: $28,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
HRT FINANCIAL LP has the largest disclosed position value at $28K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens HRT FINANCIAL LP's linked filing trail.
Disclosed position value
Top 5
HRT FINANCIAL LP
$28K
UBS Group AG
$16.3K
Cubist Systematic Strategies, LLC
$15K
GOLDMAN SACHS GROUP INC
$14.9K
GEODE CAPITAL MANAGEMENT, LLC
$13.9K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HRT FINANCIAL LP |
13F
Company
|
—
class O/S missing
|
$28,000
31,676 shares
|
— | 30 Jun 2025 |
| UBS Group AG |
13F
Company
|
—
class O/S missing
|
$16,252
18,138 shares
|
— | 30 Jun 2025 |
| Cubist Systematic Strategies, LLC |
13F
Company
|
—
class O/S missing
|
$14,986
16,727 shares
|
— | 30 Jun 2025 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
—
class O/S missing
|
$14,932
16,667 shares
|
— | 30 Jun 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$13,939
15,560 shares
|
— | 30 Jun 2025 |
| BARCLAYS PLC |
13F
Company
|
—
class O/S missing
|
$7,189
8,024 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
5
Shares
537
Rows available
5
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q4 2025 Across Filers
Q4 2025 holders
9
Q3 2025 holders
5
Holder diff
-4
| Investor | Q4 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q4 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend